Document is current
Any future updates will be listed below
-
Authors
Tong, Michael
Palmer, Nathan
Dailamy, Amir
Kumar, Aditya
Khaliq, Hammza
Han, Sangwoo
Finburgh, Emma
Wing, Madeleine
Hong, Camilla
Xiang, Yichen
Miyasaki, Katelyn
Portell, Andrew
Rainaldi, Joseph
Suhardjo, Amanda
Nourreddine, Sami
Chew, Wei Leong
Kwon, Ester J.
Mali, Prashant https://orcid.org/0000-0002-3383-1287
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (OT2OD032742, DP2NS111507)
U.S. Department of Defense (W81XWH-22-1-0401)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (U54CA274502)
American Heart Association (AHA 916973)
- License Information
-
More Information
Article History
Received: 29 January 2023
Accepted: 24 July 2024
First Online: 26 August 2024
Competing interests
: The authors have filed patents based on this work. P.M. is a scientific co-founder of Shape Therapeutics, Navega Therapeutics, Pi Bio, Boundless Biosciences and Engine Biosciences. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. The other authors declare no competing interests.
